Literature DB >> 19347411

Beta-catenin is not activated by downregulation of PTEN in osteoblasts.

Emily Hays1, Jaime Schmidt, Nalini Chandar.   

Abstract

Selective knockdown of phosphatase and tensin homolog (PTEN) has been recently shown to increase life long accumulation of bone and its ability to increase osteoblast lifespan. In order to determine how loss of PTEN function affects osteoblast differentiation, we created cell lines with stable knockdown of PTEN expression using short hairpin RNA vectors and characterized several clones. The effect of deregulated PTEN in osteoblasts was studied in relationship to cell proliferation and differentiation. Downregulation of PTEN initially affected the cell's attachment and spreading on plastic but cells recovered after a brief period of time. When cell proliferation was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, we noticed a small but significant increase in growth rates with PTEN reduction. The size of individual cells appeared larger when compared to control cells. Differentiation properties of these osteoblasts were increased as evidenced by higher expression of several of the bone markers tested (alkaline phosphatase, osteocalcin, osterix, bone morphogenetic protein 2, Cbfa1, osteoprotegerin, and receptor activator of NF-kappaB ligand) and their mineralization capacity in culture. As stabilization of beta-catenin is known to be responsible for growth deregulation with PTEN loss in other cell types, we investigated the activation of the canonical Wnt pathway in our cell lines. Immunofluorescence staining, protein expression in subcellular fractions for beta-catenin, and assays for activation of the canonical Wnt/beta-catenin signaling were studied in the PTEN downregulated cells. There was an overall decrease in beta-catenin expression in cells with PTEN knockdown. The distribution of beta-catenin was more diffuse within the cell in the PTEN-reduced clones when compared to controls where they were mostly present in cell borders. Signaling through the canonical pathway was also reduced in the PTEN knockdown cells when compared to control. The results of this study suggest that while decreased PTEN augments cell proliferation and positively affects differentiation, there is a decrease in beta-catenin levels and activity in osteoblasts. Therefore, at least in osteoblasts, beta-catenin is not responsible for mediating the activation of osteoblast differentiation with reduction in PTEN function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347411     DOI: 10.1007/s11626-009-9189-2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  32 in total

Review 1.  PIP2 and PIP3: complex roles at the cell surface.

Authors:  M P Czech
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

Review 2.  Akt-dependent transformation: there is more to growth than just surviving.

Authors:  David R Plas; Craig B Thompson
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

3.  Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.

Authors:  Elona Kolpakova; Bjorn R Olsen
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

Review 4.  Regulation of the PTEN phosphatase.

Authors:  Arne Gericke; Mary Munson; Alonzo H Ross
Journal:  Gene       Date:  2006-03-14       Impact factor: 3.688

5.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

6.  Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.

Authors:  Donald A Glass; Gerard Karsenty
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

Review 7.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  PTEN-deficient intestinal stem cells initiate intestinal polyposis.

Authors:  Xi C He; Tong Yin; Justin C Grindley; Qiang Tian; Toshiro Sato; W Andy Tao; Raminarao Dirisina; Kimberly S Porter-Westpfahl; Mark Hembree; Teri Johnson; Leanne M Wiedemann; Terrence A Barrett; Leroy Hood; Hong Wu; Linheng Li
Journal:  Nat Genet       Date:  2007-01-21       Impact factor: 38.330

Review 9.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

10.  Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.

Authors:  S Persad; A A Troussard; T R McPhee; D J Mulholland; S Dedhar
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

View more
  3 in total

1.  Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer.

Authors:  Tracy M Covey; Kornelia Edes; Gary S Coombs; David M Virshup; Frank A Fitzpatrick
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

2.  MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification.

Authors:  Jianghua Liu; Xinhua Xiao; Yingying Shen; Ling Chen; Canxin Xu; Heng Zhao; Ying Wu; Qinghai Zhang; Jing Zhong; Zhenwang Tang; Changhui Liu; Qiang Zhao; Yi Zheng; Renxian Cao; Xuyu Zu
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

Review 3.  Bone tissue and mineral metabolism in hereditary endocrine tumors: clinical manifestations and genetic bases.

Authors:  Davide Maraghelli; Francesca Giusti; Francesca Marini; Maria Luisa Brandi
Journal:  Orphanet J Rare Dis       Date:  2020-04-23       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.